Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier

Overview of attention for article published in Brain, June 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 3 X users

patent: 5 patents

Readers on

mendeley: 68 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

OPA1 antisense oligomers for treatment of conditions and diseases

Grant US-12338437-B2

United States of America

24 Jun 2025

THERAPY BY TRANS-SPLICING OF OPA1 PRE-MESSENGER RNAS FOR THE TREATMENT OF DISEASES…

Application WO-2024068898-A1

World Intellectual Property Organisation (WIPO)

04 Apr 2024

Gene editing of deep intronic mutations

Grant US-11896651-B2

United States of America

13 Feb 2024

OPA1 antisense oligomers for treatment of conditions and diseases

Grant US-11814622-B2

United States of America

14 Nov 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.